Stefania Parlato[Author] - Search Results

Year	Number of Results
2002	1
2003	2
2005	1
2009	1
2010	1
2013	1
2016	1
2017	2
2018	1
2019	1
2020	2
2021	2
2023	1
2024	0

1

Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.

Gabriele L, Fragale A, Romagnoli G, Parlato S, Lapenta C, Santini SM, Ozato K, Capone I. Gabriele L, et al. Among authors: parlato s. Cytokine Growth Factor Rev. 2021 Apr;58:66-74. doi: 10.1016/j.cytogfr.2020.10.001. Epub 2020 Oct 8. Cytokine Growth Factor Rev. 2021. PMID: 33071044 Free PMC article. Review.

2

Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects.

Fragale A, Stellacci E, Romagnoli G, Licursi V, Parlato S, Canini I, Remedi G, Buoncervello M, Matarrese P, Pedace L, Ascione B, Pizzi S, Tartaglia M, D'Atri S, Presutti C, Capone I, Gabriele L. Fragale A, et al. Among authors: parlato s. Int J Cancer. 2023 Sep 1;153(5):1080-1095. doi: 10.1002/ijc.34602. Epub 2023 Jun 9. Int J Cancer. 2023. PMID: 37293858

3

The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

Santini SM, Di Pucchio T, Lapenta C, Parlato S, Logozzi M, Belardelli F. Santini SM, et al. Among authors: parlato s. J Interferon Cytokine Res. 2002 Nov;22(11):1071-80. doi: 10.1089/10799900260442494. J Interferon Cytokine Res. 2002. PMID: 12513906 Review.

4

Tumor-on-a-chip platforms to study cancer-immune system crosstalk in the era of immunotherapy.

Parlato S, Grisanti G, Sinibaldi G, Peruzzi G, Casciola CM, Gabriele L. Parlato S, et al. Lab Chip. 2021 Jan 21;21(2):234-253. doi: 10.1039/d0lc00799d. Epub 2020 Dec 14. Lab Chip. 2021. PMID: 33315027

5

Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis.

Parlato S, Chiacchio T, Salerno D, Petrone L, Castiello L, Romagnoli G, Canini I, Goletti D, Gabriele L. Parlato S, et al. PLoS One. 2018 Jan 10;13(1):e0189477. doi: 10.1371/journal.pone.0189477. eCollection 2018. PLoS One. 2018. PMID: 29320502 Free PMC article.

6

Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer.

Maselli A, Parlato S, Puglisi R, Raggi C, Spada M, Macchia D, Pontecorvi G, Iessi E, Pagano MT, Cirulli F, Gabriele L, Carè A, Vici P, Pizzuti L, Barba M, Matarrese P, Pierdominici M, Ortona E. Maselli A, et al. Among authors: parlato s. Cells. 2019 Jul 19;8(7):750. doi: 10.3390/cells8070750. Cells. 2019. PMID: 31331091 Free PMC article.

7

3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells.

Parlato S, De Ninno A, Molfetta R, Toschi E, Salerno D, Mencattini A, Romagnoli G, Fragale A, Roccazzello L, Buoncervello M, Canini I, Bentivegna E, Falchi M, Bertani FR, Gerardino A, Martinelli E, Natale C, Paolini R, Businaro L, Gabriele L. Parlato S, et al. Sci Rep. 2017 Apr 24;7(1):1093. doi: 10.1038/s41598-017-01013-x. Sci Rep. 2017. PMID: 28439087 Free PMC article.

8

CD2+/CD14+ monocytes rapidly differentiate into CD83+ dendritic cells.

Di Pucchio T, Lapenta C, Santini SM, Logozzi M, Parlato S, Belardelli F. Di Pucchio T, et al. Among authors: parlato s. Eur J Immunol. 2003 Feb;33(2):358-67. doi: 10.1002/immu.200310010. Eur J Immunol. 2003. PMID: 12548567 Free article.

9

IFN-α regulates Blimp-1 expression via miR-23a and miR-125b in both monocytes-derived DC and pDC.

Parlato S, Bruni R, Fragapane P, Salerno D, Marcantonio C, Borghi P, Tataseo P, Ciccaglione AR, Presutti C, Romagnoli G, Bozzoni I, Belardelli F, Gabriele L. Parlato S, et al. PLoS One. 2013 Aug 16;8(8):e72833. doi: 10.1371/journal.pone.0072833. eCollection 2013. PLoS One. 2013. PMID: 23977359 Free PMC article.

10

Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells.

Fragale A, Romagnoli G, Licursi V, Buoncervello M, Del Vecchio G, Giuliani C, Parlato S, Leone C, De Angelis M, Canini I, Toschi E, Belardelli F, Negri R, Capone I, Presutti C, Gabriele L. Fragale A, et al. Among authors: parlato s. Cancer Immunol Res. 2017 Jul;5(7):604-616. doi: 10.1158/2326-6066.CIR-17-0080. Epub 2017 Jun 14. Cancer Immunol Res. 2017. PMID: 28615266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year